NT-proBNP/BNP Ratio Prognostic Calculator

Clinical calculation support · Verify results before clinical use

Biomarker ratio calculation

Enter both laboratory values in pg/mL. Interpret the result in clinical context.

NT-proBNP÷ BNP
Enter the measured NT-proBNP concentration. Zero is accepted.
Must be greater than zero because it is the denominator.

Clinical context

BNP and NT-proBNP are related biomarkers released in response to myocardial wall stress, but their measured concentrations are not interchangeable. They differ in clearance, biological properties, assay characteristics, and responses to clinical conditions.

Studies have reported prognostic associations for the NT-proBNP/BNP ratio in selected acute heart failure cohorts. This does not establish a universal ratio threshold applicable across assays, populations, or care settings.

Points to consider

  • Interpret each biomarker alongside symptoms, examination, echocardiography, renal function, age, rhythm, body mass index, and other relevant findings.
  • Assay platform, sampling time, treatment, renal dysfunction, inflammation, and nutritional status may affect measured concentrations or their ratio.
  • Use validated clinical pathways and locally validated thresholds; do not substitute this ratio for them.

References

Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.Study of 1,002 analysed acute heart failure patients; a higher ratio was associated with adverse outcomes, but groups were defined by the study median rather than universal 1.5 and 3.0 thresholds.PubMed record
Hendricks S, et al. Higher BNP/NT-proBNP levels stratify prognosis equally well in patients with and without heart failure: a meta-analysis.ESC Heart Failure. 2022;9:3198–3209. doi:10.1002/ehf2.14019.Full publication · PubMed
Clinical disclaimer: This tool performs arithmetic only. The ratio is not a stand-alone diagnostic or prognostic instrument, and the original ratio categories have not been retained because their stated cutoffs could not be verified as universally validated. Clinical decisions should follow current guidelines and the patient's overall presentation.